Brief: Medivir Q1 EBITDA Loss Narrows To SEK 20.7 Million
05/05/2020 07:35
May 5 (Reuters) - Medivir AB MVIRb.ST :
* INTERIM REPORT JANUARY - MARCH 2020
* Q1 NET TURNOVER AMOUNTED TO SEK 7.3 (2.0) MILLION
* Q1 LOSS BEFORE INTEREST, TAX, DEPRECIATION AND AMORTIZATION (EBITDA) AMOUNTED TO SEK -20.7
(-54.2) MILLION
* IN OUR INDUSTRY, COVID-19 PANDEMIC HAS IMPACTED RECRUITMENT TO CLINICAL TRIALS
* RECRUITMENT FOR ONGOING PHASE IB STUDY WITH MIV-818 IS LIKELY TO BE SLOWER THAN EXPECTED
* TOPLINE DATA FROM PHASE IB STUDY IS NOT EXPECTED UNTIL Q1 OF 2021
Source text for Eikon: ID:nWkrjqsLy
Further company coverage: MVIRb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))